# Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound

> **NCT00655512** · PHASE1 · COMPLETED · sponsor: **Technische Universität Dresden** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** pimecrolimus 1% cream
- **DRUG:** hydrocortisonacetat 1% cream
- **DRUG:** betamethasonvalerat 0,1% cream
- **DRUG:** clobetasol-17-propionat 0,05% cream
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00655512
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655512, "Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00655512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*